FDA Issues Guidance on How to Handle Illegitimate Drug Products Under Drug Supply Chain Security Act
The U.S. Food & Drug Administration recently issued its first guidance under the Drug Supply Chain Security Act seeking public comment on its proposal for how prescription drug supply chain stakeholders should […]
iwla1891 